Searched for "0".

1. Disentangling associations between multiple environmental exposures and all-cause mortality: an analysis of European administrative and traditional... (Publications)

   Disentangling associations between multiple environmental exposures and all-cause mortality: an analysis of European administrative and traditional cohorts

   Relevance:

   percentile) NDVI levels [pooled HRs: 1.054 (95% confidence interval (CI) 1.030–1.079) vs. 1.038 (95% CI 0.964–1.118)]. A similar pattern was observed for NO2. The CRI of air pollutants (PM2.5 or NO2) plus NDVI

2. Combating Over-Prescription of Antibiotics in Children: A Swiss-Tanzanian Digital Health Innovation with Promising Results (News)

   Combating Over-Prescription of Antibiotics in Children: A Swiss-Tanzanian Digital Health Innovation with Promising Results

   Relevance:

   The DYNAMIC project focuses on improving care for sick children aged 0-14 presenting to care at primary care level health facilities in low- and middle-income countries. A team of Swiss and Tanzanian medical

3. CEFALO - An international case-control study on brain tumours in children and adolescents (Projects)

   CEFALO - An international case-control study on brain tumours in children and adolescents

   Relevance:

   y associated with regular use of mobile phones (Odds ratio [OR]=1.36, 95% Confidence interval [CI]=0.92–2.02). Other exposure metrics such as time since first use or cumulative number and duration of calls

4. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic... (Publications)

   Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015

   Relevance:

   to 55.8 million (54.9 million to 56.6 million) in 2015, but age-standardised death rates fell by 17.0% (15.8-18.1) during this time, underscoring changes in population growth and shifts in global age structures [...] non-communicable diseases (NCDs), with total deaths from these causes increasing by 14.1% (12.6-16.0) to 39.8 million (39.2 million to 40.5 million) in 2015, whereas age-standardised rates decreased by

5. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic... (Publications)

   Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015

   Relevance:

   to 55.8 million (54.9 million to 56.6 million) in 2015, but age-standardised death rates fell by 17.0% (15.8-18.1) during this time, underscoring changes in population growth and shifts in global age structures [...] non-communicable diseases (NCDs), with total deaths from these causes increasing by 14.1% (12.6-16.0) to 39.8 million (39.2 million to 40.5 million) in 2015, whereas age-standardised rates decreased by

6. Legio2020 - Temporal trends in legionellosis national notification data and the effect of COVID-19 in Switzerland, 2000- 2020 (Projects)

   Legio2020 - Temporal trends in legionellosis national notification data and the effect of COVID-19 in Switzerland, 2000- 2020

   Relevance:

   time trend of annual crude notification rate for legionellosis cases from 1.1/100,000 population (CI: 0.9 - 1.4) in 2000 to 5.6/100,000 population (CI: 5.1 - 6.1) in 2020. The highest notification rate was

7. Switch Either near Suppression Or THOusand – switch to second-line versus WHO-guided standard of care for unsuppressed patients on first-line ART with... (Projects)

   Switch Either near Suppression Or THOusand – switch to second-line versus WHO-guided standard of care for unsuppressed patients on first-line ART with viremia below 1000 copies/mL: a multicenter, open-label, randomized clinical trial

   Relevance:

   virologic threshold for switching to second-line ART. Main funding Swiss National Science Foundation (IZ07Z0_160876/1; PCEFP3_181355; 323530_177576) Trial registration ClinicalTrials.gov ( NCT03088241 ), registered

8. New Findings about Diagnostic Tools for Malaria Elimination (News)

   New Findings about Diagnostic Tools for Malaria Elimination

   Relevance:

   community cross-sectional study. (2018). Lancet Infectious Diseases. DOI:10.1016/S1473-3099(18)30411-0

9. Global burden of chronic respiratory diseases and risk factors, 1990-2019: an update from the Global Burden of Disease Study 2019 (Publications)

   Global burden of chronic respiratory diseases and risk factors, 1990-2019: an update from the Global Burden of Disease Study 2019

   Relevance:

   exposure level input. FINDINGS: In 2019, CRDs were the third leading cause of death responsible for 4.0 million deaths (95% uncertainty interval 3.6-4.3) with a prevalence of 454.6 million cases (417.4-499

10. Efficacy and safety of moxidectin and albendazole compared with ivermectin and albendazole coadministration in adolescents infected with <em>Trichuris... (Publications)

    Efficacy and safety of moxidectin and albendazole compared with ivermectin and albendazole coadministration in adolescents infected with <em>Trichuris trichiura</em> in Tanzania: an open-label, non-inferiority, randomised, controlled, phase 2/3 trial

    Relevance:

    T trichiura after 14-21 days was 96.8% (95% CI 95.8 to 97.6) with moxidectin and albendazole and 99.0% (98.7 to 99.3) with ivermectin and albendazole (difference of -2.2 percentage points [-4.2 to -1.4])